Differential effects of nanoselenium doping on healthy and cancerous osteoblasts in coculture on titanium

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 351-358

  Tran, Phong A ^a   Sarin, Love ^b   Hurt, Robert H ^b   Webster, Thomas J ^b,c  

^a BROWN UNIVERSITY   (United States)

^b Brown University   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Biomaterials; Bone cancer; Coating; Nanotechnology; Orthopedics; Selenium

Indexed keywords

NANOSELENIUM; SELENIUM; TITANIUM; UNCLASSIFIED DRUG; BIOMATERIAL; NANOMATERIAL;

ARTICLE; CANCER INHIBITION; CELL DENSITY; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MATERIAL COATING; OSTEOBLAST; OSTEOSARCOMA CELL; BONE TUMOR; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; EQUIPMENT; EQUIPMENT DESIGN; MATERIALS TESTING; PATHOPHYSIOLOGY; PHYSIOLOGY; SURFACE PROPERTY;

BONE NEOPLASMS; CELL LINE; COATED MATERIALS, BIOCOMPATIBLE; COCULTURE TECHNIQUES; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; MATERIALS TESTING; NANOSTRUCTURES; OSTEOBLASTS; SELENIUM; SURFACE PROPERTIES; TITANIUM;

EID: 77956643195     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. American Cancer Society. Cancer Statistics. 2008. Available from: http://www.cancer.org/docroot/STT/STT_0.asp. Accessed on December 2nd, 2009.
2. Tran PA, Sarin L, Hurt RH, Webster TJ. Titanium surfaces with adherent selenium nanoclusters as a novel anticancer orthopedic material. J Biomed Mater Res A. 2009; Nov 15. Epub ahead of print.
3. Tran PA, Sarin L, Hurt RH, J WT. Opportunities for nanotechnologyenabled bioactive bone implants. J Mater Chem. 2009;19:2653-2659.
4. McDowell L. Minerals in Human Nutrition. Amsterdam, The Netherlands: Elsevier; 2003.
5. Combs GFJ, Combs SB. The Role of Selenium in Nutrition. Orlando, FL: Academic Press;1986.
6. Navarro-Alarcon M, Lopez-Martinez MC. Essentiality of selenium in the human body: relationship with different diseases. Sci Total Environ. 2000;249(1-3):347-371.
7. Apostolou S, Klein JO, Mitsuuchi Y, et al. Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene. 2004;23(29):5032-5040.
8. Combs GF Jr. Impact of selenium and cancer-prevention findings on the nutrition-health paradigm. Nutr Cancer. 2001;40(1):6-11.
9. Webster T. Nanophase ceramics: the future of orthopedic and dental implant material. In: Ying J, editor. Nanostructured Materials. New York, NY: Academy Press; 2001. p. 125-166.
10. Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, and CoCrMo. Biomaterials. 2004;25(19): 4731-4739.
11. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials. 2000;21(17):1803-1810.
12. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res. 2000;51(3):475-483.
13. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng. 2001;7(3):291-301.
14. Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials. 1999;20(13):1221-1227.
15. Kim JY, Khang D, Lee JE, Webster TJ. Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane. J Biomed Mater Res A. 2009;88(2):419-426.
16. Colon G, Ward BC, Webster TJ. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A. 2006;78(3):595-604.
17. Lu J, Jiang C, Kaeck M, Ganther H, Ip C, Thompson H. Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell culture model. Carcinogenesis. 1995;16(3):513-517.
18. Painter EP. The chemistry and toxicity of selenium compounds, with special reference to the selenium problem. Chem Rev. 1941;28(2): 179-213.
19. Combs GF Jr, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther. 1998;79(3):179-192.
20. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol. 1998;81(5):730-734.
21. Bakir M, Yaseen T, Sarheel A, Othman I. The determination of selenium concentration in blood and tumour tissues of breast cancer patients in Syria using instrumental neutron activation analysis. Journal of Radioanalytical and Nuclear Chemistry. 2004;260(3):607-612.
22. Liu JZ, Zhang BZ, Milner JA. Dietary selenite modifies glutathione metabolism and 7,12-dimethylbenz(a)anthracene conjugation in rats. J Nutr. 1994;124(2):172-180.
23. Kaeck M, Lu J, Strange R, Ip C, Ganther HE, Thompson HJ. Differential induction of growth arrest inducible genes by selenium compounds. Biochem Pharmacol. 1997;53(7):921-926.
24. Lu J, Pei H, Ip C, Lisk DJ, Ganther H, Thompson HJ. Effect on an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis. 1996;17(9):1903-1907.
25. Ronai Z, Tillotson JK, Traganos F, et al. Effects of organic and inorganic selenium compounds on rat mammary tumor cells. Int J Cancer. 1995;63(3):428-434.
26. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276(24):1957-1963.
27. Redman C, Scott JA, Baines AT, et al. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett. 1998;125(1-2):103-110.
28. Buser D, Nydegger T, Oxland T, et al. Interface shear strength of titanium implants with a sandblasted and acid-etched surface: a biomechanical study in the maxilla of miniature pigs. J Biomed Mater Res. 1999;45(2):75-83.
29. Wei WQ, Abnet CC, Qiao YL, et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr. 2004;79(1):80-85.
30. Combs G, Clark L. Selenium and cancer. In: Heber D, Blackburn G, Go VLW, Milner J, editors. Nutritional Oncology. New York, NY: Academic Press; 1999. p. 215-222.
31. Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev. 2004;13(5):771-778.
32. Menter DG, Sabichi AL, Lippman SM. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev. 2000;9(11):1171-1182.
33. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005;64(04):527-542.
34. Clark LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in US counties. Arch Environ Health. 1991;46(1):37-42.
35. Styblo M, Thomas DJ. Selenium modifies the metabolism and toxicity of arsenic in primary rat hepatocytes. Toxicol Appl Pharmacol. 2001;172(1):52-61.